https://news.thecrimsonreport.com/story/575793/crohns-disease-pipeline-2025-key-companies-moa-roa-and-clinical-trials-evaluation-by-delveinsight-astrazeneca-immunic-suzhou-connect-biopharmaceuticals-pfizer-bristolmyers-squibb.html 2025-08-15T10:28:16+00:00 daily 1.0 https://news.thecrimsonreport.com/story/575792/best-japanese-learning-app-2025-migaku-wins-top-honor.html 2025-08-15T10:26:25+00:00 daily 1.0 https://news.thecrimsonreport.com/story/575791/hemorrhoids-pipeline-2025-latest-fda-approvals-clinical-trials-and-emerging-therapies-assessment-by-delveinsight-citius-pharma-nivagen-pharma-edesa-biotech.html 2025-08-15T09:52:17+00:00 daily 1.0 https://news.thecrimsonreport.com/story/575790/dub-inhibitors-pipeline-2025-comprehensive-clinical-trials-and-therapies-analysis-with-key-moa-and-roa-insights-by-delveinsight-mission-therapeutics-ubiquigent-almac-discovery-ksq-therapeutics.html 2025-08-15T09:30:26+00:00 daily 1.0 https://news.thecrimsonreport.com/story/575789/the-remnant-house-welcomes-autumn-2025-with-a-warm-stylish-new-fabric-collection.html 2025-08-15T09:08:15+00:00 daily 1.0 https://news.thecrimsonreport.com/story/575788/rs-digital-launches-aipowered-seo-service-becoming-one-of-lancashires-first-ai-seo-agencies.html 2025-08-15T09:06:19+00:00 daily 1.0 https://news.thecrimsonreport.com/story/575787/polymyositis-pipeline-2025-fda-approvals-therapies-clinical-trials-and-latest-developments-unveiled-by-delveinsight-roche-pfizer-zydus-group-lupin-bausch-health-accord-healthcare-genentech.html 2025-08-15T08:50:22+00:00 daily 1.0 https://news.thecrimsonreport.com/story/575786/faa-safety-team-representative-tom-luca-schneider-to-join-pilots-to-the-rescue-mission.html 2025-08-15T08:08:24+00:00 daily 1.0 https://news.thecrimsonreport.com/story/575785/niemannpick-type-c-disease-pipeline-insight-2025-targeted-therapies-and-novel-mechanisms-aim-to-halt-neurodegeneration-delveinsight.html 2025-08-15T07:44:40+00:00 daily 1.0 https://news.thecrimsonreport.com/story/575784/mineral-metabolism-disorder-pipeline-insight-2025-targeted-hormonal-modulators-and-novel-chelation-therapies-drive-innovation-delveinsight.html 2025-08-15T07:42:17+00:00 daily 1.0